C2i Genomics

By C2i Genomics

0.0
Rating out of 5 Based on 0 reviews

C2i Genomics is the first company to offer post-surgery monitoring of cancer recurrence and progression by analyzing subtle changes in the pattern of the tumor’s DNA. Our liquid biopsy Whole Genome assay and cancer burden score will equip oncologists with vital timely information months to years before current monitoring methods are able to.

List of A comprehensive list of C2i Genomics alternatvies and competitors

Page Last Updated On October 15, 2026

Confused? Our Software expert can help!